Cancer therapy and renal injury
Open Access
- 15 September 2002
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 110 (6) , 743-745
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Renal dysfunction in allogeneic hematopoietic cell transplantationKidney International, 2002
- Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injuryKidney International, 2001
- Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cellsKidney International, 2001
- Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthaseKidney International, 2001
- Impaired IL-18 processing protects caspase-1–deficient mice from ischemic acute renal failureJournal of Clinical Investigation, 2001
- Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibodyKidney International, 1999
- Increased Nephrotoxicity of Combination Taxol and Cisplatin Chemotherapy in Gynecologic Cancers as Compared to Cisplatin AloneAmerican Journal of Nephrology, 1997
- Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancerKidney International, 1996
- Cisplatin Generates Superoxide Anion by Interaction with DNA in a Cell-Free SystemBiochemical and Biophysical Research Communications, 1994
- Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: Disturbances in glutathione peroxidase activityBiochemical and Biophysical Research Communications, 1989